Abstract:Heart failure with preserved ejection fraction (HFpEF) is defined as an inability of the ventricles to optimally accept blood from atria with blunted end- diastolic volume response by limiting the stroke volume and cardiac output. The HEpEF prevalence is higher in elderly and women and may be associated to hypertension, diabetes mellitus and atrial fibrillation. Severe exercise intolerance, manifested by dyspnea and fatigue during physical effort is the important chronic symptom in HFpEF patients, in which is … Show more
“…showed that after 3 months of aerobic exercise in preserved heart failure, there were increases in both ventilatory efficiency and aerobic capacity. After aerobic exercise, exertional dyspnea improved during performance in daily living tasks (Prado & Rocco, 2017).…”
BackgroundHeart failure is described by a lack of confirmed efficient therapies and exercise intolerance. Engagement in physical activity decreases the possibility of adverse cardiovascular consequences involving heart failure.The Purpose of the StudyDetermine the effect of different types of aerobic training on peak VO2 and ejection fraction in diastolic heart failure patients.Subject and MethodsThe study was designed as a randomized control trail. Forty‐eight eligible male patients with diastolic heart failure, aged between 50 and 65 years old, enrolled in this study. They were picked up from Police hospital outpatient clinic and were assigned to 2 equal groups in numbers. The first group (A) received aerobic exercise for the upper limb in the form of arm ergometer exercises, while the second group (B) received aerobic exercise for the lower limb in the form of cycling. Training duration for both groups was 3 sessions/week for 12 weeks. Peak VO2, and ejection fraction of both groups were measured and compared pre‐ and post‐treatment.ResultsThere was no significant difference (p > 0.05) in the ejection fraction between groups post‐treatment. However, a significant increase (p < 0.001) was observed in the peak VO2 of group B when compared to group A post‐treatment.ConclusionThere is no effect of different types of aerobic training on ejection fraction in diastolic heart failure patients, but lower limb exercise is more effective than upper limb exercise in improving peak VO2 in diastolic heart failure patients. Therefore, the current study recommended the use of lower limb exercise over upper limb exercise in training diastolic heart failure patients.Clinical Trial RegistrationThe study was registered in ClinicalTrial.gov as a clinical trial ID (NCT05637125).
“…showed that after 3 months of aerobic exercise in preserved heart failure, there were increases in both ventilatory efficiency and aerobic capacity. After aerobic exercise, exertional dyspnea improved during performance in daily living tasks (Prado & Rocco, 2017).…”
BackgroundHeart failure is described by a lack of confirmed efficient therapies and exercise intolerance. Engagement in physical activity decreases the possibility of adverse cardiovascular consequences involving heart failure.The Purpose of the StudyDetermine the effect of different types of aerobic training on peak VO2 and ejection fraction in diastolic heart failure patients.Subject and MethodsThe study was designed as a randomized control trail. Forty‐eight eligible male patients with diastolic heart failure, aged between 50 and 65 years old, enrolled in this study. They were picked up from Police hospital outpatient clinic and were assigned to 2 equal groups in numbers. The first group (A) received aerobic exercise for the upper limb in the form of arm ergometer exercises, while the second group (B) received aerobic exercise for the lower limb in the form of cycling. Training duration for both groups was 3 sessions/week for 12 weeks. Peak VO2, and ejection fraction of both groups were measured and compared pre‐ and post‐treatment.ResultsThere was no significant difference (p > 0.05) in the ejection fraction between groups post‐treatment. However, a significant increase (p < 0.001) was observed in the peak VO2 of group B when compared to group A post‐treatment.ConclusionThere is no effect of different types of aerobic training on ejection fraction in diastolic heart failure patients, but lower limb exercise is more effective than upper limb exercise in improving peak VO2 in diastolic heart failure patients. Therefore, the current study recommended the use of lower limb exercise over upper limb exercise in training diastolic heart failure patients.Clinical Trial RegistrationThe study was registered in ClinicalTrial.gov as a clinical trial ID (NCT05637125).
“…There is evidence that exercise training results in positive cardiovascular outcomes in patients with heart failure 20 . It is known that patient fatigue improves in both patients with cancer and patients with heart failure in response to exercise interventions when these populations are examined individually 14,21 . What is currently unknown is what intervention components are in the exercise interventions in cardio-oncology patients and whether positive cardiovascular and fatigue outcomes from exercise training occur in cardio-oncology patients.…”
Section: Methodsmentioning
confidence: 99%
“…20 It is known that patient fatigue improves in both patients with cancer and patients with heart failure in response to exercise interventions when these populations are examined individually. 14,21 What is currently unknown is what intervention components are in the exercise interventions in cardio-oncology patients and whether positive cardiovascular and fatigue outcomes from exercise training occur in cardio-oncology patients. To answer this, we initially developed the following question that guided our early literature searches: What is known in the existing literature about intervention components of exercise interventions among cardio-oncology patients, and what are the cardiovascular outcomes from these exercise interventions?…”
Section: Identifying Our Research Questionmentioning
Background: Cardiac toxicity in patients with cancer results from treatment-related damage to the cardiovascular system by chemotherapy, targeted agents, or thoracic radiation. Cardio-oncology patients with co-occurring cancer and cardiovascular disease frequently experience fatigue. Exercise is recommended in clinical guidelines to manage fatigue during or after cancer treatment. Purpose: The purpose of this article is to conduct a scoping review of the exercise randomized clinical trials in cardio-oncology patients, focusing on the components and effects of exercise interventions on patient cardiovascular and fatigue outcomes. Methods: A scoping review methodological framework was deemed appropriate and used. Key words for search included "cancer," "oncology," "cardio-oncology," "heart failure," "physical activity," and "exercise." Search involved systematic searches of large databases (PubMed, MEDLINE, Cochrane Review, and CINAHL) and hand searches of reference lists, key journals, webpages, and experts in the field using snowballing techniques. Results: There were 12 randomized clinical trials included in this review. Study characteristics, accordance of exercise protocols with recommendations, specific exercise training components, and cardiovascular and fatigue outcomes were mapped. Conclusions: Recommendations for addressing the gaps included focusing on non-breast-cancer patients with cardiac toxicity risks, developing precision-based prescriptions based on various medical and physiological characteristics, and adding fatigue symptom experience as an outcome variable.
“…Aerobic exercise training is able to ameliorate dyslipidemia, insulin resistance, endothelial function, and inflammatory status [ 230 ]. It is well known that exercise training exerts beneficial effects in healthy [ 231 ] and in individuals with SAH [ 232 ], T2D [ 233 ], obesity [ 234 , 235 ], cancer [ 236 ], coronary heart disease [ 237 ], and chronic heart failure [ 238 ].…”
Section: Exercise and Cardiovascular Protectionmentioning
MicroRNAs are small non-coding RNAs that regulate gene expression post-transcriptionally. They are involved in the regulation of physiological processes, such as adaptation to physical exercise, and also in disease settings, such as systemic arterial hypertension (SAH), type 2 diabetes mellitus (T2D), and obesity. In SAH, microRNAs play a significant role in the regulation of key signaling pathways that lead to the hyperactivation of the renin-angiotensin-aldosterone system, endothelial dysfunction, inflammation, proliferation, and phenotypic change in smooth muscle cells, and the hyperactivation of the sympathetic nervous system. MicroRNAs are also involved in the regulation of insulin signaling and blood glucose levels in T2D, and participate in lipid metabolism, adipogenesis, and adipocyte differentiation in obesity, with specific microRNA signatures involved in the pathogenesis of each disease. Many studies report the benefits promoted by exercise training in cardiovascular diseases by reducing blood pressure, glucose levels, and improving insulin signaling and lipid metabolism. The molecular mechanisms involved, however, remain poorly understood, especially regarding the participation of microRNAs in these processes. This review aimed to highlight microRNAs already known to be associated with SAH, T2D, and obesity, as well as their possible regulation by exercise training.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.